{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T05:04:49Z","timestamp":1770267889534,"version":"3.49.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T00:00:00Z","timestamp":1525219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"name":"Hellenic Center for Disease Control and Prevention","award":["51657"],"award-info":[{"award-number":["51657"]}]},{"name":"Hellenic Center for Disease Control and Prevention","award":["254845"],"award-info":[{"award-number":["254845"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,5]]},"DOI":"10.1093\/infdis\/jiy135","type":"journal-article","created":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T19:14:40Z","timestamp":1522178080000},"page":"26-34","source":"Crossref","is-referenced-by-count":26,"title":["Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults"],"prefix":"10.1093","volume":"218","author":[{"given":"Paraskevi F","family":"Farmaki","sequence":"first","affiliation":[{"name":"Immunobiology and Vaccinology Research Laboratory, Aghia Sophia Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C","family":"Chini","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, 3rd Internal Medicine Department, Korgialeneio-Benakeio Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos M","family":"Mangafas","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, 3rd Internal Medicine Department, Korgialeneio-Benakeio Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna T","family":"Tzanoudaki","sequence":"additional","affiliation":[{"name":"Department of Immunology and Histocompatibility, Aghia Sophia Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina P","family":"Piperi","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marios Z","family":"Lazanas","sequence":"additional","affiliation":[{"name":"Infectious Disease Unit, 3rd Internal Medicine Department, Korgialeneio-Benakeio Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vana S","family":"Spoulou","sequence":"additional","affiliation":[{"name":"Immunobiology and Vaccinology Research Laboratory, Aghia Sophia Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,5,2]]},"reference":[{"key":"key\n\t\t\t\t20180626074811_CIT0001","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QAD.0b013e32834dcf27","article-title":"Invasive pneumococcal disease among HIV-positive individuals, 2000-2009","volume":"26","author":"Yin","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180626074811_CIT0002","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180626074811_CIT0003","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/infdis\/jis212","article-title":"Pneumococcal conjugate and plain polysaccharide vaccines have divergent effects on antigen-specific B cells","volume":"205","author":"Clutterbuck","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074811_CIT0004","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fimmu.2011.00077","article-title":"Exploiting human memory B cell heterogeneity for improved vaccine efficacy","volume":"2","author":"Pauli","year":"2011","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t20180626074811_CIT0005","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nri2494","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20180626074811_CIT0006","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri3802","article-title":"Memory B cells","volume":"15","author":"Kurosaki","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20180626074811_CIT0007","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1126\/science.1241146","article-title":"Diversity among memory B cells: origin, consequences, and utility","volume":"341","author":"Tarlinton","year":"2013","journal-title":"Science"},{"key":"key\n\t\t\t\t20180626074811_CIT0008","doi-asserted-by":"crossref","first-page":"E546","DOI":"10.1073\/pnas.1416276112","article-title":"Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions","volume":"112","author":"Seifert","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180626074811_CIT0009","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/ni.1814","article-title":"Multiple layers of B cell memory with different effector functions","volume":"10","author":"Dogan","year":"2009","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20180626074811_CIT0010","first-page":"1","article-title":"Vaccination of immunocompromised individuals: IDSA clinical practice guidelines","volume":"26","author":"Konkle-Parker","year":"2014","journal-title":"HIV Clin"},{"key":"key\n\t\t\t\t20180626074811_CIT0011","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1468-1293.2011.00982.x","article-title":"Guidance on vaccination of HIV-infected children in Europe","volume":"13","author":"Menson","year":"2012","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180626074811_CIT0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/jiu632","article-title":"Stimulating evidence for pneumococcal conjugate vaccination among HIV-infected adults","volume":"212","author":"Crum-Cianflone","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074811_CIT0013","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/erv.11.8","article-title":"Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines","volume":"10","author":"Poolman","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180626074811_CIT0014","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(06)68304-9","article-title":"Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study","volume":"367","author":"Prymula","year":"2006","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626074811_CIT0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0264-410X(01)00347-4","article-title":"Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and\/or 23-valent polysaccharide vaccine among HIV-infected adults","volume":"20","author":"Feikin","year":"2001","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074811_CIT0016","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1086\/656147","article-title":"A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults","volume":"202","author":"Crum-Cianflone","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074811_CIT0017","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.vaccine.2013.04.065","article-title":"Immunogenicity and safety of pneumococcal conjugate polysaccharide and free polysaccharide vaccines alone or combined in HIV-infected adults in Brazil","volume":"31","author":"Ho","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074811_CIT0018","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4161\/hv.22836","article-title":"Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy","volume":"9","author":"Lu","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180626074811_CIT0019","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/QAD.0b013e3283389de5","article-title":"Conjugate and polysaccharide pneumococcal vaccines do not improve initial response of the polysaccharide vaccine in HIV-infected adults","volume":"24","author":"Pe\u00f1aranda","year":"2010","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180626074811_CIT0020","doi-asserted-by":"crossref","first-page":"32076","DOI":"10.1038\/srep32076","article-title":"Immunological efficacy of pneumococcal vaccine strategies in HIV-infected adults: a randomized clinical trial","volume":"6","author":"Sadlier","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180626074811_CIT0021","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/QAD.0000000000000689","article-title":"Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in HIV-infected individuals naive to pneumococcal vaccination","volume":"29","author":"Bhorat","year":"2015","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180626074811_CIT0022","doi-asserted-by":"crossref","first-page":"4782","DOI":"10.1016\/j.vaccine.2013.08.002","article-title":"Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy","volume":"31","author":"Abzug","year":"2013","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074811_CIT0023","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/infdis\/jiu631","article-title":"Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults previously vaccinated with pneumococcal polysaccharide vaccine","volume":"212","author":"Glesby","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074811_CIT0024","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1126\/science.1201730","article-title":"Different B cell populations mediate early and late memory during an endogenous immune response","volume":"331","author":"Pape","year":"2011","journal-title":"Science"},{"key":"key\n\t\t\t\t20180626074811_CIT0025","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/CVI.00721-15","article-title":"Pneumococcal vaccination in high-risk individuals: are we doing it right","volume":"23","author":"Papadatou","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t20180626074811_CIT0026","doi-asserted-by":"crossref","first-page":"944","DOI":"10.15585\/mmwr.mm6434a4","article-title":"Intervals between PCV13 and PPSV23 vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"64","author":"Kobayashi","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key\n\t\t\t\t20180626074811_CIT0027","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1080\/21645515.2016.1160987","article-title":"Association of time since pneumococcal polysaccharide vaccine receipt and CD4 count with antibody response to the 13-valent pneumococcal conjugate vaccine in HIV-infected adults","volume":"12","author":"Rossheim","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180626074811_CIT0028","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurpub\/ckw089","article-title":"Pneumococcal pneumonia vaccine breakthroughs and failures after 13-valent pneumococcal conjugated vaccine","volume":"26","author":"Almeida","year":"2016","journal-title":"Eur J Public Health"},{"key":"key\n\t\t\t\t20180626074811_CIT0029","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/cid\/ciu409","article-title":"Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with \u03b2-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine","volume":"59","author":"Papadatou","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626074811_CIT0030","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1016\/j.vaccine.2010.04.103","article-title":"The early kinetics of circulating pneumococcal-specific memory B cells following pneumococcal conjugate and plain polysaccharide vaccines in the elderly","volume":"28","author":"Baxendale","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074811_CIT0031","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.4049\/jimmunol.1203254","article-title":"Polysaccharide-specific memory B cells generated by conjugate vaccines in humans conform to the CD27+IgG+ isotype-switched memory B Cell phenotype and require contact-dependent signals from bystander T cells activated by bacterial proteins to differentiate into plasma cells","volume":"191","author":"Clarke","year":"2013","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180626074811_CIT0032","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coi.2017.03.005","article-title":"Memory B cells: total recall","volume":"45","author":"Phan","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"key\n\t\t\t\t20180626074811_CIT0033","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(00)02377-1","article-title":"23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial","volume":"355","author":"French","year":"2000","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180626074811_CIT0034","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/infdis\/jiv469","article-title":"Memory B-cell pools predict the immune response to pneumococcal conjugate vaccine in immunocompromised children","volume":"213","author":"Hoshina","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074811_CIT0035","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1097\/INF.0000000000001497","article-title":"Divergent memory B cell responses in a mixed infant pneumococcal conjugate vaccine schedule","volume":"36","author":"Tr\u00fcck","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20180626074811_CIT0036","doi-asserted-by":"crossref","first-page":"e42307","DOI":"10.1371\/journal.pone.0042307","article-title":"The impact of B-cell perturbations on pneumococcal conjugate vaccine response in HIV-infected adults","volume":"7","author":"Johannesson","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626074811_CIT0037","doi-asserted-by":"crossref","first-page":"11826","DOI":"10.1038\/ncomms11826","article-title":"Long-lived antigen-induced IgM plasma cells demonstrate somatic mutations and contribute to long-term protection","volume":"7","author":"Bohannon","year":"2016","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t20180626074811_CIT0038","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13073-017-0400-x","article-title":"High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine","volume":"9","author":"O\u2019Connor","year":"2017","journal-title":"Genome Med"},{"key":"key\n\t\t\t\t20180626074811_CIT0039","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40121-017-0166-x","article-title":"Vaccinations for the HIV-infected adult: a review of the current recommendations, part I","volume":"6","author":"Crum-Cianflone","year":"2017","journal-title":"Infect Dis Ther"},{"key":"key\n\t\t\t\t20180626074811_CIT0040","doi-asserted-by":"crossref","first-page":"s2","DOI":"10.1111\/hiv.12424","article-title":"British HIV association guidelines on the use of vaccines in HIV-positive adults 2015","volume":"17","author":"Geretti","year":"2016","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180626074811_CIT0041","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/hiv.12322","article-title":"Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons","volume":"17","author":"Ryom","year":"2016","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20180626074811_CIT0042","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/imr.12502","article-title":"B-cell responses to HIV infection","volume":"275","author":"Moir","year":"2017","journal-title":"Immunol Rev"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/1\/26\/25091063\/jiy135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T14:52:29Z","timestamp":1570978349000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/1\/26\/4990938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,5,2]]},"published-print":{"date-parts":[[2018,6,5]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy135","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7,1]]},"published":{"date-parts":[[2018,5,2]]}}}